Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease

Abstract

The retinoblastoma protein plays a critical role in regulating the G1/S transition. Less is known about the function and regulation of the homologous pocket protein p107. Here we present evidence for the posttranslational regulation of p107 by the Ca2+-activated protease calpain. Three negative growth regulators, the HMG-CoA reductase inhibitor lovastatin, the antimetabolite 5-fluorouracil, and the cyclic nucleotide dibutyryl cAMP were found to induce cell type-specific loss of p107 protein which was reversible by the calpain inhibitor leucyl-leucyl-norleucinal but not by the serine protease inhibitor phenylmethylsulfonylfluoride, caspase inhibitors, or lactacystin, a specific inhibitor of the 26S proteasome. Purified calpain induced Ca2+-dependent p107 degradation in cell lysates. Transient expression of the specific calpain inhibitor calpastatin blocked the loss of p107 protein in lovastatin-treated cells, and the half-life of p107 was markedly lengthened in lovastatian-treated cells stably transfected with a calpastatin expression vector versus cells transfected with vector alone. The data presented here demonstrate down-regulation of p107 protein in response to various antiproliferative signals, and implicate calpain in p107 posttranslational regulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirschfield J, Hoogsteen K, Liesch J and Springer J. . 1980 Proc. Natl. Acad. Sci. USA 77: 3957–3961.

  • Bagchi S, Raychaudhuri P and Nevins JR. . 1990 Cell 62: 659–669.

  • Bang Y-J, Pirnia F, Fang W-G, Kang WK, Sartor O, Whitesell L, Ha MJ, Tsokos M, Sheahan MD, Nguyen P, Niklinski WT, Myers CE and Trepel JB. . 1994 Proc. Natl. Acad. Sci. USA 91: 5330–5334.

  • Berezutskaya E, Yu B, Morozov A, Raychaudhuri P and Bagchi S. . 1997 Cell Growth Differ. 8: 1277–1286.

  • Berezutskaya E and Bagchi S. . 1997 J. Biol. Chem. 272: 30135–30140.

  • Bonvini P, Nguyen P, Trepel J and Neckers LM. . 1998 Oncogene 16: 1131–1139.

  • Boyer SN, Wazer DE and Band V. . 1996 Cancer Res. 56: 4620–4624.

  • Chen W-D, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB and Kaye FJ. . 1997 Oncogene 14: 1243–1248.

  • Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu M-L, Takano E, Maki M, Henkart P and Trepel JB. . 1997 J. Biol. Chem. 272: 28479–28484.

  • Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL and Brodeur GM. . 1991 Proc. Natl. Acad. Sci. USA 88: 139–143.

  • Clurman BE, Sheaff RJ, Thress K, Groudine M and Roberts JM. . 1996 Genes Dev. 10: 1979–1990.

  • Cooray P, Yuan Y, Schoenwaelder SM, Mitchell CA, Salem HH and Jackson SP. . 1996 Biochem. J. 318: 41–47.

  • Croall DE and Demartino GN. . 1991 Physiol. Rev. 71: 813–846.

  • Crook T, Ludwig RL, Marston NJ, Willkomm D and Vousden KH. . 1996 Virology 217: 285–292.

  • Diehl JA, Zindy F and Sherr CJ. . 1997 Genes Dev. 11: 957–972.

  • Dyson N, Buchkovich K, Whyte P and Harlow E. . 1989 Cell 58: 249–255.

  • Eto A, Akita Y, Saido TC, Suzuki K and Kawashima S. . 1995 J. Biol. Chem. 270: 25115–25120.

  • Ewen ME, Xing YG, Lawrence JB and Livingston DM. . 1991 Cell 66: 1155–1164.

  • Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, Chen SH, Paucha E and Livingston DM. . 1989 Cell 58: 257–267.

  • Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ and Schreiber SL. . 1995 Science 268: 726–731.

  • Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP and Weinberg RA. . 1987 Proc. Natl. Acad. Sci. USA 84: 9059–9063.

  • Glotzer M, Murray AW and Kirschner MW. . 1991 Nature 349: 132–138.

  • Gonen H, Shkedy D, Barnoy S, Kosower NS and Ciechanover A. . 1997 FEBS Lett. 406: 17–22.

  • Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD and Kaye FJ. . 1988 Science 241: 353–357.

  • Henkart PA. . 1996 Immunity 4: 195–201.

  • Hirai S, Kawasaki H, Yaniv M and Suzuki K. . 1991 FEBS Lett. 287: 57–61.

  • Hurford RK, Cobrinik D, Lee MH and Dyson N. . 1997 Genes Dev. 11: 1447–1463.

  • Janicke RU, Walker PA, Lin XY and Porter AG. . 1996 EMBO J. 15: 6969–6978.

  • Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. . 1993 Genes Dev. 7: 331–342.

  • Kavita U and Mizel SB. . 1995 J. Biol. Chem. 270: 27758–27765.

  • Keyomarsi K, Sandoval L, Band V and Pardee AB. . 1991 Cancer Res. 51: 3602–3609.

  • King RW, Peters JM, Tugendreich S, Rolf M, Hieter P and Kirschner MW. . 1995 Cell 81: 279–288.

  • King RW, Deshaies RJ, Peters J-M and Kirschner MW. . 1996 Science 274: 1652–1659.

  • Knudsen ES and Wang JYJ. . 1998 Oncogene 16: 1655–1663.

  • Kubbutat MH and Vousden KH. . 1997 Mol. Cell. Biol. 17: 460–468.

  • Kubbutat MH, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • Kumar S and Harvey NL. . 1995 FEBS Lett. 375: 169–173.

  • Lee M-H, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E and Jacks T. . 1996 Genes Dev. 10: 1621–1632.

  • Lees E, Faha B, Dulic V, Reed SI and Harlow E. . 1992 Genes Dev. 6: 1874–1885.

  • Liu Z-Q, Kunimatsu M, Yang J-P, Ozaki Y, Sasaki M and Okamoto T. . 1996 FEBS Lett. 385: 109–113.

  • Maki CG, Huibregtse JM and Howley PM. . 1996 Cancer Res. 56: 2649–2654.

  • Mayol X, Grana X, Baldi A, Sang N, Hu Q and Giordano A. . 1993 Oncogene 8: 2561–2566.

  • Moberg K, Starz MA and Lees JA. . 1996 Mol. Cell. Biol. 16: 1436–1449.

  • Mohans PS and Nixon RA. . 1995 J. Neurochem. 64: 859–866.

  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK. . 1995 Nature 376: 37–43.

  • Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M. . 1995 Science 269: 682–685.

  • Palombella VJ, Rando OJ, Goldberg AL and Maniatis T. . 1994 Cell 78: 773–785.

  • Qin XQ, Chittenden T, Livingston DM and Kaelin WG. . 1992 Genes Dev. 6: 953–694.

  • Rami A and Krieglstein J. . 1993 Brain Res. 609: 67–70.

  • Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL. . 1994 Cell 78: 761–771.

  • Saido TC, Sorimachi H and Suzuki K. . 1994 FASEB J. 8: 814–822.

  • Saito K, Elce JS, Hamos JE and Nixon RA. . 1993 Proc. Natl. Acad. Sci. USA 90: 2628–2632.

  • Sarin A, Wu ML and Henkart PA. . 1996 J. Exp. Med. 184: 2445–2450.

  • Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK and Hamel PA. . 1996 Crit. Rev. Biochem. Mol. Biol. 31: 237–271.

  • Sorimachi H, Saido TC and Suzuki K. . 1994 FEBS Lett. 343: 1–5.

  • Stubdal H, Zalvide J and DeCaprio JA. . 1996 J. Virol. 70: 2781–2788.

  • Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM and DeCaprio JA. . 1997 Mol. Cell. Biol. 17: 4979–4990.

  • Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, Ruderman JV and Hershko A. . 1995 Mol. Biol. Cell. 6: 185–198.

  • Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y and Ohno S. . 1987 FEBS Lett. 220: 271–277.

  • Szekely L, Uzvolgyi E, Jiang WQ, Durko M, Wiman KG, Klein G and Sumegi J. . 1991 Cell Growth Differ. 2: 287–295.

  • Tortora G, Pepe S, Bianco C, Baldassarre G, Budillon A, Clair T, Cho-Chung YS, Bianco AR and Ciardiello F. . 1994 Oncogene 9: 3233–3240.

  • Treier M, Staszewski LM and Bohmann D. . 1994 Cell 78: 787–798.

  • Walowitz JL, Bradley ME, Chen S and Lee T. . 1998 J. Biol. Chem. 273: 6656–6661.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Weintraub SJ, Prater CA and Dean DC. . 1992 Nature 358: 259–261.

  • Whyte P. . 1995 Semin. Cancer Biol. 6: 83–90.

  • Zalvide J, Stubdal H and DeCaprio JA. . 1998 Mol. Cell. Biol. 18: 1408–1415.

  • Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N and Harlow E. . 1993 Genes Dev. 7: 1111–1125.

Download references

Acknowledgements

We thank Mr Alfred W Alberts, Merck and Company, Inc., for generously providing lovastatin. We are grateful to Dr Frederic Kaye for critical review of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jang, J., Lee, S., Choi, Y. et al. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease. Oncogene 18, 1789–1796 (1999). https://doi.org/10.1038/sj.onc.1202497

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202497

Keywords

This article is cited by

Search

Quick links